PDLIM1, a novel miR-3940-5p target, regulates the malignant progression of diffuse large B-cell lymphoma
These findings suggest that the miR-3940-5p/PDLIM1 axis may play a crucial role in DLBCL pathogenesis and could potentially be exploited for therapeutic interventions.
Authors
- Jinfeng Zhu (ORCID: https://orcid.org/0000-0002-7820-9897)
- Jinyang Zheng
- Xihu Yao
- Xiongpeng Zhu (ORCID: https://orcid.org/0009-0006-9850-0354)
- Chuntuan Li
- Xiaofeng Li (ORCID: https://orcid.org/0000-0001-5185-9163)
- Shaoxiong Wang (ORCID: https://orcid.org/0000-0002-3579-3093)
- Huifang Xiao
Institutions
- Fujian Medical University (CN)
Publication Details
- Journal
- Cancer Biology & Therapy
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1080/15384047.2024.2429175
- Citations
- 2
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.48